[1]
2025. The Immunological Effect of a Gleevec Drug as Tyrosin Kinase Inhibitor in Auto-immune Thyroid Peroxidase in Iraqi Patientswith Chronic Myeloid Leukemia. Iraqi Journal of Science. 56, 4c (Mar. 2025), 3399–3404. DOI:https://doi.org/10.24996/ijs.2015.56.4c.%g.